Cationized gelatin-HVJ envelope with sodium borocaptate improved the BNCT efficacy for liver tumors in vivo
2011

Improving Boron Neutron Capture Therapy for Liver Tumors

publication Evidence: moderate

Author Information

Author(s): Fujii Hitoshi, Matsuyama Akifumi, Komoda Hiroshi, Sasai Masao, Suzuki Minoru, Asano Tomoyuki, Doki Yuichiro, Kirihata Mitsunori, Ono Koji, Tabata Yasuhiko, Kaneda Yasufumi, Sawa Yoshiki, Lee Chun Man

Primary Institution: Osaka University Graduate School of Medicine

Hypothesis

Can cationized gelatin-HVJ envelope with sodium borocaptate enhance the efficacy of BNCT for liver tumors?

Conclusion

The study found that CG-HVJ-E-BSH significantly improved the effectiveness of BNCT for treating liver tumors without harming surrounding normal tissues.

Supporting Evidence

  • CG-HVJ-E reduced hemagglutination activity by half compared to HVJ-E.
  • Higher 10B concentrations were achieved in tumor cells with CG-HVJ-E-BSH than with BSH.
  • CG-HVJ-E-BSH significantly increased the survival time of tumor-bearing mice compared to BSH.

Takeaway

Researchers created a new delivery method for a cancer treatment that helps target liver tumors better while keeping healthy tissue safe.

Methodology

The study involved developing a new vector for boron delivery and testing its effectiveness in a murine model of liver tumors.

Limitations

The study was conducted in a murine model, which may not fully replicate human responses.

Participant Demographics

Female C3H/HeN Jcl mice, 8-12 weeks old.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1748-717X-6-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication